Andrea Cuconati

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Baruch S. Blumberg Institute, Drexel University, Hoffmann-La Roche Inc.. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrea Cuconati. Retrieved from https://idiyas.com/inventor/andrea-cuconati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 33.3

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 43(Granted Patents)

Location History:

Oreland, PA (US) (2013 - 2019)
Doylestown, PA (US) (2021)

Company Filing History:

8 out of 17

Baruch S. Blumberg Institute

Hoffmann-La Roche Inc.

patents

4. 1 out of 57

Arbutus Biopharma Corporation

patents

5. 1 out of 1

Enantigen Therapeutics, Inc.

patent

6. 1 out of 2

Institute for Hepatitis and Virus Research

patents

where one patent can have more than one assignee

Years Active: 2013-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10913734 - Substituted aminothiazoles (2021-02-09),

2. 10214567 - Tagged hepadnavirus E antigen and its use in screening antiviral substances (2019-02-26),

3. 10087173 - Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication (2018-10-02),

4. 10072047 - Tagged hepadnavirus e antigen and its use in screening antiviral substances (2018-09-11),

5. 9657013 - Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of use (2017-05-23),

6. 9533990 - Inhibitors of secretion of hepatitis B virus antigens (2017-01-03),

7. 9168260 - Benzodiazepine compounds with anti-flavivirus activity (2015-10-27),

8. 8921381 - Inhibitors of secretion of hepatitis B virus antigens (2014-12-30),

9. 8609668 - Substituted triazolo[1,5-A]pyrimidines as antiviral agents (2013-12-17),

Title: Andrea Cuconati: Innovator in Biochemical Research

Introduction

Andrea Cuconati is a prominent inventor based in Oreland, PA (US). She has made significant contributions to the field of biochemical research, particularly in the development of innovative compounds and methods for screening antiviral substances. With a total of 9 patents, her work has had a substantial impact on the scientific community.

Latest Patents

Among her latest patents, one notable invention is related to substituted aminothiazoles. This patent describes compositions comprising these compounds and methods for their production and application. Another significant patent focuses on the tagged hepadnavirus E antigen and its use in screening antiviral substances. This invention outlines methods for screening anti-hepadnaviral substances, specifically targeting the inhibition of covalently closed circular (ccc) DNA of hepadnaviruses, such as the hepatitis B virus. The patent also provides nucleic acid sequences encoding the tagged hepadnavirus E antigen and includes kits for use in the screening methods.

Career Highlights

Throughout her career, Andrea has worked with esteemed institutions, including the Baruch S. Blumberg Institute and Drexel University. Her research has been pivotal in advancing the understanding of viral infections and developing potential therapeutic strategies.

Collaborations

Andrea has collaborated with notable colleagues in her field, including Timothy Michael Block and Xiaodong Xu. These partnerships have further enriched her research and contributed to her innovative work.

Conclusion

Andrea Cuconati is a distinguished inventor whose contributions to biochemical research have led to significant advancements in antiviral screening methods and compounds. Her ongoing work continues to inspire and influence the scientific community.

Profile summary based on public USPTO records.